Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-011935
Filing Date
2018-05-08
Accepted
2018-05-08 19:17:52
Documents
2
Period of Report
2018-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1634
2 EX-24 DOCUMENT attachment1.htm EX-24 4177
  Complete submission text file 0000899243-18-011935.txt   7181
Mailing Address C/O WATSON PHARMA INC 360 MOUNT KEMBLE AVE MORRISTOWN NJ 07960
Business Address
BOYER ANDREW S (Reporting) CIK: 0001239546 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38485 | Film No.: 18816288

Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations